Literature DB >> 10648438

Axonal changes in chronic demyelinated cervical spinal cord plaques.

G Lovas1, N Szilágyi, K Majtényi, M Palkovits, S Komoly.   

Abstract

Imaging and pathomorphological studies in multiple sclerosis suggest that axonal injury and axonal loss are playing a crucial role in those with persistent disability and long-standing disease. Although the existence of axonal injury in multiple sclerosis is proven, especially in the zone of active inflammation, the effect of chronic inflammation on the axons remains elusive. The aim of this study was to perform a quantitative morphometrical analysis, estimating axonal loss and evaluating axonal degenerative changes in cervical spinal cord samples of patients suffering from secondary progressive multiple sclerosis. Completely demyelinated plaques, normal appearing white matter (NAWM) and control material from anatomically identical regions of the cord have been compared. Neurofilament immunostaining was used for identification of the axons. We observed a significant reduction of axonal density (number of axons/mm(2)) in multiple sclerosis, both in the plaque and in the NAWM compared with the control cases. Axons under approximately 3.3 microm diameter seemed to be more affected. The intensity of the immunostaining was significantly reduced in the plaque compared with either NAWM or control. Our results on the cervical cord combined with other observations support the concept of slow axonal degeneration rather than acute damage as a cause of chronic disability in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648438     DOI: 10.1093/brain/123.2.308

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  81 in total

1.  The effects of paranodal myelin damage on action potential depend on axonal structure.

Authors:  Ehsan Daneshi Kohan; Behnia Shadab Lashkari; Carolyn Jennifer Sparrey
Journal:  Med Biol Eng Comput       Date:  2017-08-03       Impact factor: 2.602

2.  Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Authors:  Natalia M Moll; Anna M Rietsch; Smitha Thomas; Amy J Ransohoff; Jar-Chi Lee; Robert Fox; Ansi Chang; Richard M Ransohoff; Elizabeth Fisher
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

3.  Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

Authors:  Fumitaka Sato; Hiroki Tanaka; Faris Hasanovic; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2011-02

4.  Using diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis.

Authors:  Lauren V Zollinger; Tae Ho Kim; Kenneth Hill; Eun K Jeong; John W Rose
Journal:  J Magn Reson Imaging       Date:  2011-03       Impact factor: 4.813

Review 5.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

6.  Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.

Authors:  Yong Wang; Peng Sun; Qing Wang; Kathryn Trinkaus; Robert E Schmidt; Robert T Naismith; Anne H Cross; Sheng-Kwei Song
Journal:  Brain       Date:  2015-02-26       Impact factor: 13.501

Review 7.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

Review 8.  Axonal pathology and demyelination in viral models of multiple sclerosis.

Authors:  Jane E Libbey; Thomas E Lane; Robert S Fujinami
Journal:  Discov Med       Date:  2014 Jul-Aug       Impact factor: 2.970

9.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Effects of white, grey, and pia mater properties on tissue level stresses and strains in the compressed spinal cord.

Authors:  Carolyn J Sparrey; Geoffrey T Manley; Tony M Keaveny
Journal:  J Neurotrauma       Date:  2009-04       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.